PHAS
Bank of New York Mellon’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-34,960
| Closed | -$121K | – | 4500 |
|
|
2021
Q1 | $121K | Sell |
34,960
-2,005
| -5% | -$6.94K | ﹤0.01% | 4136 |
|
|
2020
Q4 | $125K | Sell |
36,965
-2,791
| -7% | -$9.44K | ﹤0.01% | 4047 |
|
|
2020
Q3 | $139K | Hold |
39,756
| – | – | ﹤0.01% | 3921 |
|
|
2020
Q2 | $182K | Sell |
39,756
-1,495
| -4% | -$6.84K | ﹤0.01% | 3813 |
|
|
2020
Q1 | $136K | Buy |
41,251
+5,732
| +16% | +$18.9K | ﹤0.01% | 3820 |
|
|
2019
Q4 | $217K | Hold |
35,519
| – | – | ﹤0.01% | 3889 |
|
|
2019
Q3 | $148K | Sell |
35,519
-2,650
| -7% | -$11K | ﹤0.01% | 3959 |
|
|
2019
Q2 | $501K | Buy |
+38,169
| New | +$501K | ﹤0.01% | 3599 |
|